1. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk factors, and clinical implications. Clin Psychol Rev 1998;18:765-794.
2. Emslie GJ, Rush AJ, Weinberg WA, Gullion CM, Rintelmann J, Hughes CW. Recurrence of major depressive disorder in hospitalized children and adolescents. J Am Acad Child Adolesc Psychiatry 1997;36:785-792.
3. Engelberg H. Low serum cholesterol and suicide. Lancet 1992;339:727-729.
4. Papakostas GI, Öngür D, Iosifescu DV, Mischoulon D, Fava M. Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses. Eur Neuropsychopharmacol 2004;14:135-142.
5. Comings DE, MacMurray JP, Gonzalez N, Ferry L, Peters WR. Association of the serotonin transporter gene with serum cholesterol levels and heart disease. Mol Genet Metab 1999;67:248-253.
6. Myint AM, Kim YK. Cytokine-serotonin interaction through IDO: a neurodegeneration of depression. Med Hypotheses 2003;61:519-525.
7. Francis KT. Psychologic correlates of serum indicators of stress in men: a longitudinal study. Psychosom Med 1979;41:617-628.
8. Terao T, Iwata N, Kanazawa K, Takano T, Takahashi N, Hayashi T, et al. Low serum cholesterol levels and depressive state in human dock visitors. Acta Psychiatr Scand 2000;101:231-234.
9. Sullivan PF, Joyce PR, Bulik CM, Mulder RT, Oakley-Browne M. Total cholesterol and suicidality in depression. Biol Psychiatry 1994;36:472-477.
11. Glueck CJ, Kuller FE, Hamer T, Rodriguez R, Sosa F, Sieve-Smith L, et al. Hypocholesterolemia, hypertriglyceridemia, suicide, and suicide ideation in children hospitalized for psychiatric diseases. Pediatr Res 1994;35:602-610.
12. Apter A, Laufer N, Bar-Sever M, Har-Even D, Ofek H, Weizman A. Serum cholesterol, suicidal tendencies, impulsivity, aggression, and depression in adolescent psychiatric inpatients. Biol Psychiatry 1999;46:532-541.
13. Louise S, Warrington NM, McCaskie PA, Oddy WH, Zubrick SR, Hands B, et al. Associations between anxious-depressed symptoms and cardiovascular risk factors in a longitudinal childhood study. Prev Med 2012;54:345-350.
14. Jeffery AN, Hyland ME, Hosking J, Wilkin TJ. Mood and its association with metabolic health in adolescents: a longitudinal study, EarlyBird 65. Pediatr Diabetes 2014;15:599-605.
16. Lewinsohn PM, Rohde P, Seeley JR. Major depressive disorder in older adolescents: prevalence, risk, and clinical implications. Clin Psychol Rev 1998;18:765-794.
17. Knuiman JT, West CE, Katan MB, Hautvast JG. Total cholesterol and high density lipoprotein cholesterol levels in populations differing in fat and carbohydrate intake. Arteriosclerosis 1987;7:612-619.
20. Ministry of Health and Welfare, M.O.H.A. Guideline for KNHANES Data Analysis Using SPSS. Cheongju: Korea Center for Disease Control and Prevention; 2013.
23. Tedders SH, Fokong KD, McKenzie LE, Wesley C, Yu L, Zhang J. Low cholesterol is associated with depression among US household population. J Affect Disord 2011;135:115-121.
24. Ancelin ML, Carriere I, Boulenger JP, Malafosse A, Stewart R, Cristol JP, et al. Gender and genotype modulation of the association between lipid levels and depressive symptomatology in community-dwelling eldery. (The ESPRIT Study). Biol Psychiatry 2010;68:125-132.
25. Papakostas GI, Petersen T, Mischoulon D, Hughes ME, Alpert JE, Nierenberg AA, et al. Serum cholesterol and serotonergic function in major depressive disorder. Psychiatry Res 2003;118:137-145.
26. Scanlon SM, Williams DC, Schloss P. Membrane cholesterol modulates serotonin transporter activity. Biochemistry 2001;40:10507-10513.
27. Sonawalla SB, Papakostas GI, Petersen TJ, Yeung AS, Smith MM, Sickinger AH, et al. Elevated cholesterol levels associated with nonresponse to fluoxetine treatment in major depressive disorder. Psychosomatics 2002;43:310-316.
28. McCann BS, Magee MS, Broyles FC, Vaughan M, Albers JJ, Knopp RH. Acute psychological stress and epinephrine infusion in normolipidemic and hyperlipidemic men: effects on plasma lipid and apoprotein concentrations. Psychosom Med 1995;57:165-176.